HM-61713 (BI-1482694) is an orally available small molecule, mutant-selective inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity.
Product Name: HM-61713 (BI-1482694)|Cat No.:DC8819|CAS: 1802181-20-9|Other names: NSC 163501,Antibiotic AT-125,U 42126|MW: |
HM61713, also known as BI 1482694, is an orally available small molecule, mutant-selective inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity. EGFR inhibitor HM61713 binds to and inhibits mutant forms of EGFR, thereby leading to cell death of EGFR-expressing tumor cells.
For research only, not for human use!
没有评论:
发表评论